Ongoing research aims to further understand the mechanisms of T790M-induced resistance and to develop new therapeutic strategies. This includes the development of next-generation inhibitors and combination therapies that can prevent or overcome resistance. Additionally, advancements in liquid biopsy technology continue to improve the early detection and monitoring of T790M and other resistance mutations.
